@article{b74a347b1530438d96061bd914f04322,
title = "Special stem cells for bone",
abstract = "Mesenchymal stem cells (MSCs) are multipotential in vitro, but their endogenous properties are poorly defined. In this issue of Cell Stem Cell, Park et al. (2012) report that an MSC-like, osteolineage-directed Mx1+ population generates new osteoblasts at sites of bone damage, suggesting its potential for skeletal repair and regeneration.",
author = "Mone Zaidi and Li Sun and Blair, {Harry C.}",
note = "Funding Information: M.Z., S.L., and H.C.B. acknowledge support from the National Institutes of Health. M.Z. consults for Amgen and Questcor, and is a named inventor of a pending patent application related to osteoclastic bone resorption filed by the Mount Sinai School of Medicine (MSSM). In the event the pending or issued patent is licensed, he would be entitled to a share of any proceeds MSSM receives from the licensee.",
year = "2012",
month = mar,
day = "2",
doi = "10.1016/j.stem.2012.02.012",
language = "English",
volume = "10",
pages = "233--234",
journal = "Cell Stem Cell",
issn = "1934-5909",
publisher = "Cell Press",
number = "3",
}